Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Wegscheider

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
European Heart Journal|August 1, 1990
Controversial indications. Rationale for thrombolysis: later than 4-6 h from symptom onset, and in patients with smaller myocardial infarctions. The ISAM Study GroupR Schröder, T Linderer, T Brüggemann, et al.
Die Medizinische Welt|April 30, 1982
[Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV]W Schwartzkopff, C Luley, W Scheffler, et al.
Circulation|August 1, 1987
Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) StudyR Schröder, K L Neuhaus, T Linderer, et al.
Blood|December 12, 2001
High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytesJ Zweigner, H J Gramm, O C Singer, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 2, 2017
Effectiveness of one-to-one peer support for patients with severe mental illness - a randomised controlled trialC I Mahlke, S Priebe, K Heumann, et al.
Journal of the American College of Cardiology|October 13, 1998
Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement. HIT-4 Trial Group. Hirudin for Improvement of ThrombolysisU Zeymer, K L Neuhaus, K Wegscheider, et al.
The American Journal of Cardiology|October 15, 1989
Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction (results from the ISAM study)R Schröder, K L Neuhaus, T Linderer, et al.
Circulation|October 1, 1989
Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study GroupS N Willich, T Linderer, K Wegscheider, et al.
European Heart Journal|May 15, 2001
Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trialU Zeymer, R Schröder, U Tebbe, et al.
Biomedica Biochimica Acta|January 1, 1984
Prostaglandin production in patients with pulmonary embolismT Friedrich, J Lichey, S Nigam, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
European Heart Journal|August 1, 1990
Controversial indications. Rationale for thrombolysis: later than 4-6 h from symptom onset, and in patients with smaller myocardial infarctions. The ISAM Study GroupR Schröder, T Linderer, T Brüggemann, et al.
Die Medizinische Welt|April 30, 1982
[Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV]W Schwartzkopff, C Luley, W Scheffler, et al.
Circulation|August 1, 1987
Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) StudyR Schröder, K L Neuhaus, T Linderer, et al.
Blood|December 12, 2001
High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytesJ Zweigner, H J Gramm, O C Singer, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 2, 2017
Effectiveness of one-to-one peer support for patients with severe mental illness - a randomised controlled trialC I Mahlke, S Priebe, K Heumann, et al.
Journal of the American College of Cardiology|October 13, 1998
Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement. HIT-4 Trial Group. Hirudin for Improvement of ThrombolysisU Zeymer, K L Neuhaus, K Wegscheider, et al.
The American Journal of Cardiology|October 15, 1989
Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction (results from the ISAM study)R Schröder, K L Neuhaus, T Linderer, et al.
Circulation|October 1, 1989
Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study GroupS N Willich, T Linderer, K Wegscheider, et al.
European Heart Journal|May 15, 2001
Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trialU Zeymer, R Schröder, U Tebbe, et al.
Biomedica Biochimica Acta|January 1, 1984
Prostaglandin production in patients with pulmonary embolismT Friedrich, J Lichey, S Nigam, et al.
Pageof 10